Virafin receives emergency use approval

  • IASbaba
  • April 26, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

Virafin receives emergency use approval

Part of: GS Prelims and GS –II – Health & GS-III – Sci & tech 

In news

Key takeaways 

  • Virafin is a pegylated interferon alpha-2b(PegIFN), which when subcutaneously injected to the patient in the early stages of infection, resulted in their faster recovery.
  • The clinical trials have confirmed the safety, tolerability and efficacy of Virafin. 
  • The studies also reported that Viarfin reduces viral load and aid in managing the disease in a better way, such as reduction in the need for supplemental oxygen. 

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates